OROPHARYNX SQUAMOUS CELL CARCINOMA
Clinical trials for OROPHARYNX SQUAMOUS CELL CARCINOMA explained in plain language.
Never miss a new study
Get alerted when new OROPHARYNX SQUAMOUS CELL CARCINOMA trials appear
Sign up with your email to follow new studies for OROPHARYNX SQUAMOUS CELL CARCINOMA, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New drug cocktail aims to shrink Hard-to-Treat head and neck tumors
Disease control Recruiting nowThis study tests whether combining two drugs, sacituzumab govitecan and cetuximab, can shrink tumors in people with advanced head and neck cancer that has gotten worse after first-line therapy. About 40 adults with certain types of head and neck cancer will receive the drug combi…
Matched conditions: OROPHARYNX SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Memorial Sloan Kettering Cancer Center • Aim: Disease control
Last updated May 22, 2026 13:55 UTC
-
New weekly drug combo offers hope for head and neck cancer patients unable to take standard chemo
Disease control Recruiting nowThis study tests a weekly combination of chemotherapy (carboplatin and paclitaxel) plus immunotherapy (pembrolizumab) in 32 people with metastatic head and neck cancer who cannot take the standard drug 5-fluorouracil. The goal is to see if this regimen shrinks tumors better than …
Matched conditions: OROPHARYNX SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: Wake Forest University Health Sciences • Aim: Disease control
Last updated May 19, 2026 12:00 UTC
-
Blood test may spare throat cancer patients from unnecessary radiation
Knowledge-focused Recruiting nowThis study looks at whether a simple blood test can tell which throat cancer patients can safely skip radiation after surgery. About 61 people with HPV-related throat cancer will have their blood tested before and after surgery. If the test is negative after surgery, they won't g…
Matched conditions: OROPHARYNX SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: University of Maryland, Baltimore • Aim: Knowledge-focused
Last updated May 26, 2026 08:33 UTC
-
Simple blood test could revolutionize throat cancer Follow-Up
Knowledge-focused Recruiting nowThis study looks at whether a blood test that measures HPV DNA can help find throat cancer recurrence earlier in patients with HPV-related oropharyngeal cancer. About 420 adults who have finished treatment and are cancer-free at 3 months will be followed. The goal is to see if th…
Matched conditions: OROPHARYNX SQUAMOUS CELL CARCINOMA
Phase: PHASE2 • Sponsor: UNICANCER • Aim: Knowledge-focused
Last updated May 26, 2026 08:28 UTC
-
Blood test may predict throat cancer comeback
Knowledge-focused Recruiting nowThis study follows 220 people with HPV-related throat cancer after treatment to see if two things can predict if the cancer returns: changes in certain genes (TRAF3 and CYLD) and levels of HPV DNA in the blood. Participants will give blood samples and have regular CT scans. The g…
Matched conditions: OROPHARYNX SQUAMOUS CELL CARCINOMA
Sponsor: UNC Lineberger Comprehensive Cancer Center • Aim: Knowledge-focused
Last updated May 20, 2026 11:56 UTC